清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Evaluation of Decompression and Interlaminar Stabilization Compared with Decompression and Fusion for the Treatment of Lumbar Spinal Stenosis: 5-year Follow-up of a Prospective, Randomized, Controlled Trial.

可视模拟标度 背痛 脊柱融合术 腰痛 狭窄
作者
Michael J. Musacchio,Carl Lauryssen,Reginald J. Davis,Hyun W. Bae,John H. Peloza,Richard D. Guyer,Jack E. Zigler,Donna D. Ohnmeiss,Scott P. Leary
出处
期刊:The International Journal of Spine Surgery [International Journal of Spine Surgery]
卷期号:10: 6-6 被引量:24
标识
DOI:10.14444/3006
摘要

Introduction If nonoperative treatment for lumbar stenosis fails, surgery may be considered. This traditionally includes decompression often combined with fusion. Desire for less extensive surgery led to developing new techniques and implants, including an interlaminar device designed with the goal of providing segmental stability without fusion, following decompression. The purpose of this study was to investigate 5-year outcomes associated with an interlaminar device. Methods This prospective, randomized, controlled trial was conducted at 21 centers. Patients with moderate to severe lumbar stenosis at one or two contiguous levels and up to Grade I spondylolisthesis were randomized (2:1 ratio) to decompression and interlaminar stabilization (D+ILS; n=215) using the coflex® Interlaminar Stabilization® device (Paradigm Spine, LLC) or decompression and fusion with pedicle screws (D+PS; n=107). Clinical evaluations were made preoperatively and at 6 weeks and 3, 6, 12, 18, 24, 36, 48, and 60 months postoperatively. Overall Food and Drug Administration success criteria required that a patient meet 4 criteria: 1) >15 point improvement in Oswestry Disability Index (ODI) score; 2) no reoperation, revision, removal, or supplemental fixation; 3) no major device-related complication; and 4) no epidural steroid injection after surgery. Results At 5 years, 50.3% of D+ILS vs. 44% of D+PS patients (p>0.35) met the composite success criteria. Reoperation/revision rates were similar in the two groups (16.3% vs. 17.8%; p >0.90). Both groups had statistically significant improvement through 60 months in ODI scores with 80.6% of D+ILS patients and 73.2% of D+PS patients demonstrating >15 point improvement (p>0.30). VAS, SF-12, and ZCQ scores followed a similar pattern of maintained significant improvement throughout follow-up. On the SF-12 and ZCQ, D+ILS group scores were statistically significantly better during early follow-up compared to D+PS. In the D+ILS group, foraminal height, disc space height, and range of motion at the index level were maintained through 5 years. Conclusion Both treatment groups achieved and maintained statistically significant improvements on multiple outcome assessments throughout 5-year follow-up. On some clinical measures, there were statistically significant differences during early follow-up favoring D+ILS. At no point were there significant differences favoring D+PS. Results of this 5-year follow-up study demonstrate that decompression and interlaminar stabilization with coflex is a viable alternative to traditional decompression and fusion in the treatment of patients with moderate to severe stenosis at one or two lumbar levels. Level of Evidence and Ethical Statements This is a Level I study. Institutional approval was received at each of the sites participating in the trial. Each patient gave informed consent to participate in the trial.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
朱莉莉完成签到,获得积分10
16秒前
名侦探柯基完成签到 ,获得积分10
23秒前
龙猫爱看书完成签到,获得积分10
1分钟前
Hello应助Logan采纳,获得10
1分钟前
林非鹿完成签到 ,获得积分10
1分钟前
Ava应助科研通管家采纳,获得10
1分钟前
华仔应助科研通管家采纳,获得10
1分钟前
1分钟前
Logan发布了新的文献求助10
1分钟前
沙海沉戈完成签到,获得积分0
1分钟前
Logan完成签到,获得积分10
2分钟前
凤里完成签到 ,获得积分10
2分钟前
林利芳完成签到 ,获得积分10
2分钟前
天问完成签到 ,获得积分10
3分钟前
小二郎应助周运来采纳,获得10
3分钟前
3分钟前
周运来发布了新的文献求助10
3分钟前
GQ完成签到,获得积分10
4分钟前
4分钟前
YUYUYU发布了新的文献求助10
4分钟前
周运来完成签到,获得积分10
4分钟前
小新小新完成签到 ,获得积分10
5分钟前
zzhui完成签到,获得积分10
5分钟前
喜悦的飞飞完成签到,获得积分10
6分钟前
misstwo完成签到,获得积分10
7分钟前
香蕉觅云应助YUYUYU采纳,获得10
7分钟前
杨晓柳发布了新的文献求助10
7分钟前
杨晓柳完成签到,获得积分10
8分钟前
spark810应助科研通管家采纳,获得30
11分钟前
19950220完成签到,获得积分10
11分钟前
应夏山完成签到 ,获得积分10
13分钟前
qcrcherry完成签到,获得积分10
13分钟前
spark810应助科研通管家采纳,获得30
13分钟前
spark810应助科研通管家采纳,获得30
13分钟前
科研通AI2S应助科研通管家采纳,获得10
13分钟前
al完成签到 ,获得积分10
13分钟前
稻子完成签到 ,获得积分10
15分钟前
Ava应助lovelife采纳,获得10
16分钟前
17分钟前
zhangsan完成签到,获得积分10
17分钟前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 400
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3154987
求助须知:如何正确求助?哪些是违规求助? 2805698
关于积分的说明 7865869
捐赠科研通 2463969
什么是DOI,文献DOI怎么找? 1311686
科研通“疑难数据库(出版商)”最低求助积分说明 629728
版权声明 601853